VANGUARD GROUP INC - ARIAD PHARMACEUTICALS INC ownership

ARIAD PHARMACEUTICALS INC's ticker is ARIA and the CUSIP is 04033A100. A total of 1 filers reported holding ARIAD PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 2.0%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of ARIAD PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2016$181,513,000
+1.0%
14,591,103
+11.1%
0.01%
-9.1%
Q3 2016$179,737,000
+91.1%
13,129,074
+3.2%
0.01%
+83.3%
Q2 2016$94,033,000
+18.1%
12,724,399
+2.1%
0.01%
+20.0%
Q1 2016$79,653,000
+4.9%
12,465,396
+2.6%
0.01%0.0%
Q4 2015$75,912,000
-84.7%
12,145,786
-63.2%
0.01%
-73.7%
Q3 2015$497,586,000
+421.5%
32,975,494
+185.8%
0.02%
+216.7%
Q2 2015$95,419,000
+3.6%
11,537,938
+3.3%
0.01%0.0%
Q1 2015$92,071,000
+24.8%
11,173,568
+4.1%
0.01%
+20.0%
Q4 2014$73,757,000
+30.9%
10,735,985
+2.9%
0.01%
+25.0%
Q3 2014$56,353,000
-17.0%
10,435,719
-2.1%
0.00%
-20.0%
Q2 2014$67,878,000
-18.9%
10,655,939
+2.6%
0.01%
-28.6%
Q1 2014$83,699,000
+18.7%
10,384,378
+0.5%
0.01%
+16.7%
Q4 2013$70,492,000
-61.5%
10,335,936
+3.8%
0.01%
-66.7%
Q3 2013$183,198,000
+8.1%
9,956,395
+2.7%
0.02%0.0%
Q2 2013$169,484,0009,690,3450.02%
Other shareholders
ARIAD PHARMACEUTICALS INC shareholders Q1 2017
NameSharesValueWeighting ↓
Sarissa Capital Management LP 12,850,000$94,961,00026.95%
Consonance Capital Management LP 8,845,742$65,370,0009.25%
Opaleye Management Inc. 1,250,000$9,238,0006.17%
Tamarack Advisers, LP 2,100,000$15,519,0005.95%
IRONWOOD INVESTMENT MANAGEMENT LLC 293,352$2,168,0001.62%
Camber Capital Management LP 4,000,000$29,560,0001.43%
Palo Alto Investors LP 2,535,117$18,735,0001.42%
Granite Point Capital Management, L.P. 430,890$3,184,0001.37%
1492 Capital Management LLC 202,500$1,496,0001.34%
HighVista Strategies LLC 869,100$6,423,0001.23%
View complete list of ARIAD PHARMACEUTICALS INC shareholders